<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-PO1TXLYI/fb831b80-5b19-4018-942d-1adaadcfda7e/PDF"><dcterms:extent>613 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-PO1TXLYI/00e7cfd0-076e-4c61-b0f8-bfadcb9576cd/TEXT"><dcterms:extent>49 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1929-2026"><edm:begin xml:lang="en">1929</edm:begin><edm:end xml:lang="en">2026</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-PO1TXLYI"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp" /><dcterms:issued>2023</dcterms:issued><dc:creator>Poglajen, Gregor</dc:creator><dc:creator>Poljančič, Laura</dc:creator><dc:contributor>Poljančič, Laura</dc:contributor><dc:creator>Zbačnik, Rok</dc:creator><dc:format xml:lang="sl">številka:9/10</dc:format><dc:format xml:lang="sl">letnik:92</dc:format><dc:format xml:lang="sl">str. 398-408</dc:format><dc:identifier>DOI:10.6016/ZdravVestn.3433</dc:identifier><dc:identifier>ISSN:1318-0347</dc:identifier><dc:identifier>COBISSID:176373251</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-PO1TXLYI</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko zdravniško društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Zdravniški vestnik</dcterms:isPartOf><dc:subject xml:lang="en">cardiac allograft rejection</dc:subject><dc:subject xml:lang="en">cardiac allograft vasculopathy</dc:subject><dc:subject xml:lang="en">heart transplant</dc:subject><dc:subject xml:lang="en">magnetic resonance</dc:subject><dc:subject xml:lang="sl">magnetnoresonančno slikanje</dc:subject><dc:subject xml:lang="sl">presajeno srce</dc:subject><dc:subject xml:lang="sl">vaskulopatija</dc:subject><dc:subject xml:lang="sl">zavrnitvena reakcija</dc:subject><dcterms:temporal rdf:resource="1929-2026" /><dc:title xml:lang="sl">Magnetnoresonančno slikanje srca pri bolnikih s presajenim srcem| Cardiac magnetic resonance in heart transplant recipients|</dc:title><dc:description xml:lang="sl">Allograft rejection is a limiting factor of short-term survival after heart transplantation; the long-term survival of this patient population is limited mainly by cardiac allograft vasculopathy. It is crucial that cardiac allograft rejections and/or vasculop-athy are detected in the early stages of the disease when successful treatment is still possible and the allograft is not yet irreversibly damaged. Currently, the routine technique for vasculopathy detection is coronary angiography, and the gold standard for the detection of cardiac allograft rejection remains endomyocardial biopsy. The invasiveness, necessity of hospitalization, and suboptimal sensitivity of both diagnostic techniques led the researchers to evaluate other non-inva-sive diagnostic methods for early detection of cardiac allograft rejection and vasculopathy, among which cardiac magnetic resonance is considered to have the highest potential to replace the invasive methods. In this review, we aim to summarize current knowledge on the use of cardiac magnetic resonance in patients after heart transplantation and to outline the fu-ture perspectives of this imaging modality in the early diagnosis of cardiac allograft vasculopathy and allograft rejection</dc:description><dc:description xml:lang="sl">Omejujoči dejavnik kratkoročnega preživetja pri bolnikih po presaditvi srca je zavrnitev presadka, dolgoročno preživetje pa omejuje predvsem vaskulopatija presadka. Za bolnike po presaditvi srca je ključnega pomena, da morebitno zavrnitve-no reakcijo ali pa vaskulopatijo presadka odkrijemo v zgodnji fazi bolezni, ko so terapevtski ukrepi še učinkoviti in presa-dek še ni nepovratno poškodovan. Danes je prva izbira pri diagnosticiranju vaskulopatije koronarografija, zlati standard pri diagnosticiranju zavrnitvene reakcije pa je endomiokardna biopsija. Zaradi invazivnosti, potrebe po hospitalni obravnavi in suboptimalni občutljivosti obeh preiskav se vse več raziskav usmerja v neinvazivne diagnostične pristope, med katerimi se je kot obetajoča preiskava izkazalo zlasti magnetnoresonančno slikanje srca. V preglednem članku bomo predstavili uporabnost magnetnoresonančnega slikanja srca pri bolnikih s presajenim srcem, njegove prednosti in izhodišča za razvoj pri zgodnjem diagnosticiranju zavrnitvenih reakcij in vaskulopatije presadka v prihodnosti</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-PO1TXLYI"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-PO1TXLYI" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-PO1TXLYI/fb831b80-5b19-4018-942d-1adaadcfda7e/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by-nc/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko zdravniško društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-PO1TXLYI/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-PO1TXLYI" /></ore:Aggregation></rdf:RDF>